Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of MESCO PHARMA. For more details, see the MESCO PHARMA quarterly results and MESCO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 4.9 |
No. of shares | m | 20.32 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 7.6/3.6 |
No. of Mths Year Ending |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
5-Yr Chart Click to enlarge
|
---|
MESCO PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | 12 | 12 | 9 | |
Low | Rs | NA | NA | 9 | 9 | 7 | |
Sales per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Earnings per share (Unadj.) | Rs | -0.1 | 0 | -0.2 | 0 | 0 | |
Diluted earnings per share | Rs | -0.1 | -0.0 | -0.2 | -0.0 | -0.0 | |
Cash flow per share (Unadj.) | Rs | -0.1 | 0 | -0.2 | 0 | 0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | -5.1 | -5.2 | -5.4 | -5.4 | -5.4 | |
Adj. book value per share | Rs | -5.1 | -5.2 | -5.4 | -5.4 | -5.4 | |
Shares outstanding (eoy) | m | 20.32 | 20.32 | 20.32 | 20.32 | 20.32 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 0 | |
Avg P/E ratio | x | 0 | 0 | -53.1 | -216.2 | -4,046.3 | |
P/CF ratio (eoy) | x | 0 | 0 | -53.1 | -216.2 | -4,046.3 | |
Price / Book Value ratio | x | 0 | 0 | -2.0 | -1.9 | -1.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 218 | 212 | 162 | |
Total wages/salary | Rs m | 0 | 0 | 0 | 0 | 0 |
MESCO PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | 0 | 0 | 0 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 0 | 0 | 0 | 0 | 0 | |
Gross profit | Rs m | -3 | -1 | -4 | -1 | 0 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | -3 | -1 | -4 | -1 | 0 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -3 | -1 | -4 | -1 | 0 | |
Gross profit margin | % | 0 | 0 | 0 | 0 | 0 | |
Effective tax rate | % | -0.4 | 0 | 0 | 0 | 0 | |
Net profit margin | % | 0 | 0 | 0 | 0 | 0 |
MESCO PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 0 | 0 | 0 | 0 | 0 | |
Current liabilities | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net working cap to sales | % | 0 | 0 | 0 | 0 | 0 | |
Current ratio | x | 4.9 | 5.7 | 1.7 | 2.6 | 0.2 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 0 | 0 | 0 | 0 | 0 | |
Net fixed assets | Rs m | 2 | 2 | 2 | 2 | 2 | |
Share capital | Rs m | 197 | 197 | 197 | 197 | 197 | |
"Free" reserves | Rs m | -302 | -302 | -307 | -308 | -308 | |
Net worth | Rs m | -104 | -105 | -109 | -110 | -110 | |
Long term debt | Rs m | 107 | 107 | 111 | 112 | 112 | |
Total assets | Rs m | 2 | 2 | 2 | 2 | 2 | |
Interest coverage | x | 0 | 0 | 0 | 0 | 0 | |
Debt to equity ratio | x | -1.0 | -1.0 | -1.0 | -1.0 | -1.0 | |
Sales to assets ratio | x | 0 | 0 | 0 | 0 | 0 | |
Return on assets | % | -104.4 | -35.2 | -165.2 | -44.9 | -2.1 | |
Return on equity | % | 2.5 | 0.8 | 3.8 | 0.9 | 0 | |
Return on capital | % | -107.5 | -36.2 | -182.9 | -48.0 | -2.3 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
MESCO PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -3 | -1 | -4 | -1 | -0 | |
From Investments | Rs m | 0 | 0 | 0 | 0 | 0 | |
From Financial Activity | Rs m | 3 | 1 | 4 | 1 | -0 | |
Net Cashflow | Rs m | 0 | 0 | 0 | -0 | -0 |
Share Holding
Shareholding as on Dec 2020
|
Company Information
|
COMP SEC: N S Parameswaran | YEAR OF INC: 1986 | BSE CODE: 500274 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare MESCO PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.